News

GSK’s share price is still significantly down on the year, despite very robust H1 results, leaving it looking extremely ...
Glaxosmithkline, which has major operations in Montgomery County, is set to receive a major settlement, writes Anthony O. Goriainoff for the Wall Street ...
London: GSK plc has announced that a supplemental New Drug Application for gepotidacin has been accepted by the US Food and ...
South Korea is fast becoming a focal point for global biopharmaceutical licensing, with deal values reaching $7.86 billion ...
Assembly Biosciences is advancing its herpes drug to Phase II trials after it showed 94% antiviral efficacy in a Phase Ib ...
The 40 Under 40, Rami Fakhouri of Goldman Ismail is honored for his work in products liability.
Sarepta’s troubles had nothing to do with Arrowhead’s assets, and yet both companies have seen their stock prices decline ...
US FDA accepts for priority review GSK’s sNDA for gepotidacin for oral treatment of uncomplicated urogenital gonorrhoea: London, UK Tuesday, August 12, 2025, 10:00 Hrs [IST] GSK ...
GlaxoSmithKline ( ($GB:GSK) ) just unveiled an announcement. GSK plc has announced the purchase of 494,426 of its own ordinary shares as part of ...
Austin family advocates for getting fully vaccinated for meningococcal disease after daughter lost her legs and fingers as a ...
Shortly after that, the CDC overhauled its vaccine recommendations in COVID, nixing its endorsement of the shots for pregnant women and healthy children. At the time, RFK Jr. said he “couldn’t be more ...